Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bengbu
Clinical trial register · China

Clinical Trials in Bengbu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Baotou 1 Beijing 1 Bengbu 1 Changchun 1 Changsha 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca34 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11 The First Affiliated Hospital of Bengbu Medical University10 Merck Sharp & Dohme LLC6 Shanghai Henlius Biotech5 Eli Lilly and Company5 Hoffmann-La Roche4 Janssen Research & Development, LLC4 DualityBio Inc.4 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.4 Beijing InnoCare Pharma Tech Co., Ltd.4 argenx3 BeOne Medicines3 First Affiliated Hospital of Wannan Medical College3 BioNTech SE3 Second Affiliated Hospital, Zhejiang University, School of Medicine3 Mirati Therapeutics Inc.3 Bristol-Myers Squibb3 Sichuan Baili Pharmaceutical Co., Ltd.3 Antengene Biologics Limited2 Amgen2 TJ Biopharma Co., Ltd.2 Affiliated Hospital of Nantong University2 Betta Pharmaceuticals Co., Ltd.2 Anhui Provincial Hospital2 Qilu Pharmaceutical Co., Ltd.2 Nanjing Legend Biotech Co.2 Takeda2 Abbisko Therapeutics Co, Ltd2 Shenzhen Ausa Pharmed Co.,Ltd2 AbbVie2 Shanghai Junshi Bioscience Co., Ltd.2 Boehringer Ingelheim2 Nanjing Leads Biolabs Co.,Ltd2 Shanghai Pharmaceuticals Holding Co., Ltd2 RemeGen Co., Ltd.2 Sun Yat-sen University2 Ascentage Pharma Group Inc.2 Jiangsu Simcere Pharmaceutical Co., Ltd.1 Nanjing Bioheng Biotech Co., Ltd.1 InxMed (Shanghai) Co., Ltd.1 JHM BioPharma (Tonghua) Co. , Ltd.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 Shanghai Jiaolian Drug Research and Development Co., Ltd1 Capital Medical University1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Laekna Limited1 Waterstone Pharmaceutical (Wuhan) Co., LTD.1 NGGT (Suzhou) Biotechnology Co., Ltd.1 Hangzhou Sumgen Biotech Co., Ltd.1 Transcenta Therapeutics (Hangzhou) Co., Ltd.1 Eisai Co., Ltd.1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 MediLink Therapeutics (Suzhou) Co., Ltd.1 Sellas Life Sciences Group1 Advenchen Laboratories, LLC1 Pfizer1 Lepu Medical Technology (Beijing) Co., Ltd.1 Taizhou Hanzhong biomedical co. LTD1 China Immunotech (Beijing) Biotechnology Co., Ltd.1 Vividion Therapeutics, Inc.1 Ocumension Therapeutics (Suzhou) Co., Ltd1 InnoCare Pharma Inc.1 UCB Biopharma SRL1 Tarapeutics Science Inc.1 NewAmsterdam Pharma1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Zai Lab (Shanghai) Co., Ltd.1 InventisBio Co., Ltd1 Ruitherapeutics Co., LTD1 Genor Biopharma Co., Ltd.1 Biotheus Inc.1 Huahui Health1 CStone Pharmaceuticals1 Shanghai Institute Of Biological Products1 Innovent Biologics (Suzhou) Co. Ltd.1 Yan Yang, MD, Ph.D1 InnoBM Pharmaceuticals Co., Ltd.1 Heronova Pharmaceuticals1 Jazz Pharmaceuticals1 Arrowhead Pharmaceuticals1 Akeso1 Shanghai TTM-Bio Technology Co., Ltd1 Climb Bio, Inc.1 Jiangsu Carephar Pharmaceutical Co., Ltd.1 Hutchmed1 Astellas Pharma Global Development, Inc.1 TCRx Therapeutics Co.Ltd1 Resonova (Shanghai) Medtech Limited1 Nanjing First Hospital, Nanjing Medical University1 LeonaBio1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Dermavon Holdings Limited1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Vertex Pharmaceuticals Incorporated1 Klus Pharma Inc.1 Teligene US1 Johnson & Johnson Enterprise Innovation Inc.1 3D Medicines (Sichuan) Co., Ltd.1 Basilea Pharmaceutica1 Zhejiang University1 Beijing Continent Pharmaceutical Co, Ltd.1 Sir Run Run Shaw Hospital1 Clear sponsor filter
Target enrolment
to

Trials with a site in Bengbu

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Baotou, Beijing, Bengbu, Changchun, Changsha, Chengdu, Dalian, Dongguan
2025-09-30
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/bengbu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Bengbu that also match the filters currently applied.

How many clinical trials are recruiting in Bengbu?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bengbu), 1 studies
PhaseStudiesRecruitingShare
Phase 2/311100%

Most active sponsors

Lead sponsors with the most studies (Bengbu)
Lead sponsorStudiesRecruiting
Vertex Pharmaceuticals Incorporated11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.